| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |